Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
455.34
+12.29 (+2.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
42
43
Next >
2 Market-Beating Stocks With Major Catalysts on the Way
June 17, 2023
Can these companies keep climbing?
Via
The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
June 15, 2023
All three of these stocks should be huge winners over the long run.
Via
The Motley Fool
2 Magnificent Growth Stocks to Buy Before the Next Bull Market
June 15, 2023
A bull market could be the tip of the iceberg for these businesses.
Via
The Motley Fool
Macro Muddle Coming Up As Market Exceeds Expectations, Small Caps Gain Ground
June 12, 2023
For the bull run to continue we need broader market participation from SMID caps.
Via
Talk Markets
5 Stocks to Buy With Explosive 500% Potential
June 12, 2023
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential.
Via
InvestorPlace
$1000 Invested In This Stock 15 Years Ago Would Be Worth $10,000 Today
June 07, 2023
Via
Benzinga
CRISPR Therapeutics: A Galaxy's Worth of Deep Value
May 31, 2023
Wall Street is at max pessimism with this biotech, which might be a big mistake.
Via
The Motley Fool
Expert Ratings for Vertex Pharmaceuticals
May 30, 2023
Via
Benzinga
2 Biotech Stocks That Could Help Make You a Fortune
June 12, 2023
Biotech stocks with cutting-edge therapies have the potential to generate substantial returns over time.
Via
The Motley Fool
3 No-Brainer Stocks to Buy in June
June 10, 2023
These biopharma stocks could be big winners.
Via
The Motley Fool
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application
June 09, 2023
The FDA has accepted the application for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG (NASDAQ: CRSP) exa-cel for sickle cell disease and transfusion-dependent
Via
Benzinga
Vertex/CRISPR Partnered Cell Therapy Shows Encouraging In Sickle Cell Disease, Thalassemia Patients
June 09, 2023
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP) announced that pivotal trials for exagamglogene autotemcel (exa-cel) for transfusion-dependent...
Via
Benzinga
Why Is CRISPR Therapeutics (CRSP) Stock Moving Today?
June 09, 2023
CRISPR Therapeutics (CRSP) stock is on the move Friday after the company revealed data from its CLIMB-111 and CLIMB-121 clinical trials.
Via
InvestorPlace
Crispr Stock Slips; The FDA Could Approve The First CRISPR-Based Gene-Editing Drug In Just Six Months
June 09, 2023
The agency said it will make an approval decision on Crispr's exa-cel in December.
Via
Investor's Business Daily
2 Top Biotech Stocks to Buy in June
June 09, 2023
Both companies have solid therapy franchises and continue to expand their horizons.
Via
The Motley Fool
5 Top Stocks to Buy in June
June 08, 2023
There are always buying opportunities in the stock market.
Via
The Motley Fool
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
June 08, 2023
Today, CRISPR has reached an important turning point.
Via
The Motley Fool
A New S&P 500 Bull Market Is Nearly Here: 3 No-Brainer Stocks to Buy Sooner Rather Than Later
June 07, 2023
These stocks are already performing well but could kick into higher gear in a new S&P 500 bull market.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy for June
June 06, 2023
These stocks have what it takes to deliver long-term growth.
Via
The Motley Fool
Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?
June 03, 2023
This company might be worth a premium.
Via
The Motley Fool
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
June 03, 2023
All three trounced the market over the past 10 years.
Via
The Motley Fool
Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer
May 31, 2023
These businesses have considerable growth runways ahead.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
May 30, 2023
Via
Benzinga
Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More
May 28, 2023
Analysts could be too reserved about this biotech stock's prospects.
Via
The Motley Fool
Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever
May 28, 2023
These stocks have what it takes to help you build long-term wealth.
Via
The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
May 27, 2023
These stocks should be winners in good times and bad times.
Via
The Motley Fool
2 Supercharged Stocks to Buy With $100
May 27, 2023
These stocks are climbing in the double digits.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 26, 2023
Via
Benzinga
2 Biotech Stocks That Could Help Set You Up for Life
May 26, 2023
These two promising companies have the potential to beat the market over time.
Via
The Motley Fool
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
May 25, 2023
On Thursday, Gilead Sciences stock had its Relative Strength (RS) Rating upgraded to 81, up from 78 a day earlier.
Via
Investor's Business Daily
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
42
43
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.